Pneumocystis carinii pneumonia as a presenting feature of X-linked hyper-IgM syndrome.
Mílledge
J
J
Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Kakakios
A
A
Gillis
J
J
Fitzgerald
D A
DA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D045422:Continuous Positive Airway Pressure / Q000379:methods; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D053307:Hyper-IgM Immunodeficiency Syndrome, Type 1 / Q000175:diagnosis* / Q000628:therapy; D007223:Infant; D015278:Intensive Care Units, Pediatric; D008297:Male; D045363:Pneumocystis carinii / Q000302:isolation & purification*; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis* / Q000628:therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents